Abstract:Objective to investigate the clinical effect and safety of percutaneous transhepatic portal vein stent placement(PTPVS) combined with transcatheter arterial chemoembolization(TACE) for the treatment of hepatocellular carcinoma(HCC) complicated by tumor thrombus in portal vein,and to discuss the possible factors affecting the prognosis.Methods According to the inclusion criteria and exclusion criteria,62 patients with clinically-confirmed HCC associated with portal vein tumor thrombus,who were encountered during the period from January 2009 to October 2010 in authors' hospital,were enrolled in this prospective two-arm nonrandomized trail.These patients were randomly divided into study group(n = 32) and control group(n = 30).Simple TACE(THP 40 mg/m2,Oxaliplatin 135 mg/m2,mitomycin C 6 mg/m2,lipiodol 5-20 ml) was used in patients of control group,while PTPVS with subsequent TACE was employed in patients of study group.PTPVS failed in two patients of study group.The overall survival time and the safety were used as the evaluation indexes.All patients were followed up.The procedure-related complications occurred after PTPVS were recorded.A data base on clinical information and follow-up outcome of all patients was set up and SPSS13.0 was used for statistical analysis.Median survival time and survival curve of the patients were analyzed by Kaplan-Meier method.A log-rank analysis was performed to identify group differences.Cox's proportional hazards model was used to analyze the variables affecting the patients' prognosis.Results The median overall survival time of the study group was 6.5 months,while the median overall survival time of the control group was 4.5 months(hazard ratio in the study group: 0.57,95%,confidence interval: 0.328-0.992,P = 0.037).Significant difference in the median overall survival time existed between the two groups.The cumulative survival rates at 3,6,12 and 18 months in the study group were 70%,56.7%,10% and 3.3%,respectively.In the study group,no procedure-related complications occurred within 1 week after the operation.The long-term complications in the study group included hepatic encephalopathy(n = 2,6.6%),upper gastrointestinal hemorrhage such as hematemesis and melen(n = 3,10%) and hepatorenal syndrome(n = 1,3.3%).Conclusion For the treatment of patients with HCC complicated by partial obstruction of the main trunk or the rst-order branch of the portal vein due to tumor thrombus,PTPVS combined with TACE is safe and effective.this combination therapy can improve The median survival time of patients receiving this combination therapy is about two months longer than that of patients receiving TACE alone.

Clinical Investigation of Chemoembolization of Hepatic Artery Combined with Portal Venous in Treating the Moderate and Advanced Hepatic Carcinomas

Combined Three Intervened Treatment of TACE,PEI And PVC in Advanced Liver Cancer

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Evaluation of the Therapeutic Effect of Hepatic Arterial Chemoembolization Combined with Portal Chemoembolization for Advanced Hepatic Carcinomas

Three-dimensional Conformal Radiotherapy in Combination with Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.

[Comparison of Therapeutic Effects Between Transcatheter Arterial Chemoembolization and Transcatheter Arterial-Portal Venous Double Chemoembolization in Treatment of Moderate and Advanced Stages of Primary Liver Carcinoma].

Evaluation of CT-guided ~(125)I Seed Implantation Combined with Transcatheter Arterial Chemoembolization in Treating Portal Vein Tumor Thrombus Associated with Hepatocellular Carcinoma

Clinical research of percutaneous microwave coagulation therapy with transcatheter arterial chemoembolization and portal vein chemotherapy on advanced liver cancer

Clinical Study of Advanced Primary Hepatocellular Carcinoma Cells after TACE with Use of Portal Vein Perfusion Chemothepary

Clinical Investigation of Combined Three Intervened Treatment of TACE.PVC.And PEI in Advanced Hepatic Cancer

Transarterial Chemoembolization for Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis.

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

Efficacy combined transcatheter arterial chemoembolization(TACE)and radiotherapy for advanced primary liver cancer

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Effect of TACE Combined with Stereotactic Body X-knife on the Patients with Hepatocellular Carcinoma

Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis

Efficacy of Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

A Clinical Study of Transcatheter Arterial Chemoembolization Combined with Three-dimensional Conformal Radiotherapy in Primary Hepatocellular Carcinoma

Portal Vein Stent Placement Combined with TACE for the Treatment of Hepatocellular Carcinoma Associated with Tumor Thrombus in Portal Vein

Hepatic Arterial Chemoembolization Combined with DSA-guided Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma:Evaluation of the Therapeutic Effect